(Q48328976)

10 February 2018

title

Schizophrenia: more evidence for less glutamate. (English)

1 reference

10 February 2018

1 reference

Paul D Morrison

1

1 reference

10 February 2018

Lyn S Pilowsky

series ordinal

2

1 reference

10 February 2018

publication date

1 January 2007

1 reference

10 February 2018

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 February 2018

volume

7

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

29-31

1 reference

10 February 2018

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Neuregulin 1 and susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Neuregulin and ErbB receptor signaling pathways in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Neuregulins: versatile growth and differentiation factors in nervous system development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Ampakines and the threefold path to cognitive enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

Src kinases: a hub for NMDA receptor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.29

21 January 2018

Identifiers

DOI

10.1586/14737175.7.1.29

1 reference

10 February 2018

1 reference

10 February 2018